Literature DB >> 2173100

Virologic and pathogenetic aspects of cytomegalovirus infection.

J E Grundy1.   

Abstract

Cytomegalovirus (CMV) is a ubiquitous agent that rarely causes disease in immunocompetent humans but is an important cause of morbidity and mortality in the immunocompromised. A number of host and viral factors are associated with pathology following CMV infection. CMV can be found at many sites in the body but only causes disease at some of these and then only in certain patient populations. In some situations the mechanism underlying disease is direct viral replication, but in others, particularly CMV pneumonitis in allogeneic transplant recipients, an immunopathologic basis is strongly implicated. An important factor in the pathogenesis of infection and the expression of symptomatic disease is the source of CMV infection-whether it arises from an exogenous source or is due to reactivation of latent endogenous virus. Exogenous infection can occur in previously seronegative individuals or in those with prior exposure to the virus. In renal transplant recipients both types of exogenous infection have been associated with disease. Another factor that affects the interaction between CMV and its host is the modulating effect of the virus on the host immune response, the mechanism of which remains unknown.

Entities:  

Mesh:

Year:  1990        PMID: 2173100     DOI: 10.1093/clinids/12.supplement_7.s711

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  12 in total

1.  Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs.

Authors:  R Holtappels; M F Pahl-Seibert; D Thomas; M J Reddehase
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Increased adherence of CD2 peripheral blood lymphocytes to cytomegalovirus-infected fibroblasts is blocked by anti-LFA-3 antibody.

Authors:  J E Grundy; G S Pahal; A N Akbar
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

Review 3.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection.

Authors:  J Podlech; R Holtappels; M F Pahl-Seibert; H P Steffens; M J Reddehase
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 5.  Cytomegalovirus infection in the gastrointestinal tract.

Authors:  R Chetty; D E Roskell
Journal:  J Clin Pathol       Date:  1994-11       Impact factor: 3.411

6.  Cytomegalovirus colitis in individuals without apparent cause of immunodeficiency.

Authors:  F H Ng; T N Chau; T C Cheung; C Kng; S Y Wong; W F Ng; K C Lee; E Chan; S T Lai; W C Yuen; C M Chang
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

7.  Modulation of RANTES production by human cytomegalovirus infection of fibroblasts.

Authors:  S Michelson; P Dal Monte; D Zipeto; B Bodaghi; L Laurent; E Oberlin; F Arenzana-Seisdedos; J L Virelizier; M P Landini
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

Review 8.  Cytomegalovirus infection in solid organ transplantation: economic implications.

Authors:  Ananya Das
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

9.  Human herpesvirus 6 and human herpesvirus 7 infections in renal transplant recipients and healthy adults in Turkey.

Authors:  S Yalcin; T Karpuzoglu; G Suleymanlar; G Mutlu; T Mukai; T Yamamoto; Y Isegawa; K Yamanishi
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Cytomegalovirus Retinitis in an ALL Child during Maintenance Therapy Treated Successfully with Intravenous Ganciclovir.

Authors:  Hande Celiker; Ayse Karaaslan; Eda Kepenekli Kadayifci; Serkan Atici; Ahmet Soysal; Haluk Kazokoglu; Ahmet Koc
Journal:  Case Rep Ophthalmol Med       Date:  2014-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.